How Pieces Technologies’ AI is Driving Clinical Efficiency

By Michael Awood

September 14, 2023

Significant progress is being made in healthcare by Pieces Technologies Inc.

Healthcare professionals use its Artificial Intelligence (AI) platform to manage cases, plan discharges, and reduce hospital stays. Recently, the AI wrote its one-millionth clinical summary – in just seven months. This displays the role and impact that AI can have in healthcare.

The Pieces system uses advanced technology and human help to ensure high accuracy while maintaining a hallucination rate of less than 0.1%. “Hallucinations” refer to instances where the AI produces incorrect or nonsensical outputs. However, Pieces shows great promise in this area with a considerable improvement compared to existing models. This high accuracy is further evidenced by the reduced need for edits in the system’s output.

The software is a trusted tool for healthcare professionals, supporting various clinical procedures and contributing to efforts aimed at reducing patient stay duration and readmission rates.
This achievement highlights the potential of applied clinical generative AI in healthcare delivery. Pieces Technologies has committed to safety, transparency, and accountability to improve healthcare outcomes and operations.

Pieces Technologies is leading the way in redefining healthcare through AI, achieving clinical efficiency and patient care. The system is set to be implemented in pediatric hospital environments soon, further expanding its impact. This highlights the importance of AI in healthcare, not to surpass benchmarks, but to enhance patient care and clinical outcomes.

 

Cover image source: PR Newswire. Link in the reference URL

Reference url

Recent Posts

U.S. withdraws from WHO
     

U.S. Withdraws from WHO: Impact on Global Health Security and Relations

🚨 *What does the U.S. withdrawing from the WHO mean for global health?*
President Trump’s executive order to begin the withdrawal process raises serious concerns about the future of global health security. From financial disparities to a shift in international partnerships, the implications could reshape our collective ability to combat pandemics and health crises.

Dive into our article to understand the potential impacts on health outcomes and the quest for new alliances.

#SyenzaNews #globalhealth #healthcarepolicy

semaglutide NAION risk
    

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence

🔍 Is semaglutide linked to vision loss?

The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.

Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!

#SyenzaNews #Pharmaceuticals #HealthcarePolicy

cervical cancer screening
        

Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in KwaZulu-Natal

💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.

Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.

#SyenzaNews #HealthEconomics #oncology #GlobalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.